Ozgur Yasar Akbal
Ozgur Yasar Akbal has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Cihangir Kaymaz
Department of Cardiology İstanbul Hospital Başkent University İstanbul Turkey
14 shared publications - Ali Karagöz
Department of Cardiology, Kartal Koşuyolu High Specialization Education and Research Hospital, Istanbul, Türkiye
13 shared publications - Berhan Keskin
Department of Cardiology, Istanbul Medipol University, Medipol Mega University Hospital, Türkiye
12 shared publications - Hacer Ceren Tokgöz
Department of Cardiology, Koşuyolu Training and Research Hospital, İstanbul, Türkiye
12 shared publications - Seda Tanyeri
Kartal Kosuyolu High Specialization Education and Research Hospital
11 shared publications - Süleyman Çağan Efe
Department of Cardiology Kartal Kosuyolu Research and Education Hospital Istanbul Turkey
11 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (6) , 264-272
Is it Time to Reappraise for Black-Box Warning on AngioJet Rheolytic Thrombectomy in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis
Background: AngioJet rheolytic thrombectomy (ART) system has been widely used as a catheter-directed treatment (CDT) method in acute pulmonary embolism (PE), however, there has been a controversy regarding the safety of its use. In this systematic review and meta-analysis, we evaluated the efficacy and safety outcomes of ART in patients with PE. Methods: Our meta-analysis have been based on search in the MEDLINE, EMBASE, and Cochrane Library for studies published up to August 2022. The primary outcomes were overall pooled rates of major bleeding (MB) and minor bleeding (mB), worsening renal function (WRF), bradycardia/conduction disturbance (BCD), and PE-related and all- cause mortality in patients who underwent ART. Results: Among the 233 studies documented at initial search, 24 studies were eligible for meta-analysis, and a total of 427 PE patients who underwent ART were evaluated. Overall pooled rates of MB and mB were 9.6% (95% CI 5.9%-15.2%) and 9.2% (95% CI 6.1%13.6%), transient BCD and WRF were 18.2% (95% CI 12.4%-26%) and 15% (95% CI 10%21.8%), and PE-related death and all-cause death were 12.7% (95% CI 9.1%-17.3%) and 15% (95% CI 11%-20%), respectively. However, significant heterogeneity and some evidence of funnel plot asymmetry and publication bias were noted for MB, BCD and WRF, but not for PE-related death and all-cause death. Conclusion: Overall pooled rates of bleeding events, BCD and WRF episodes, PE-related death and all-cause death may be considered as encouraging results for efficacy and safety issues of ART utilization in specific scenarios of acute PE, and a reappraisal for black-box warning on ART seems to be necessary.
- 1 January 2024
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 28 (6) , 264-272
Open AccessIs it Time to Reappraise for Black-Box Warning on AngioJet Rheolytic Thrombectomy in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis
Background: AngioJet rheolytic thrombectomy (ART) system has been widely used as a catheter-directed treatment (CDT) method in acute pulmonary embolism (PE), however, there has been a controversy regarding the safety of its use. In this systematic review and meta-analysis, we evaluated the efficacy and safety outcomes of ART in patients with PE. Methods: Our meta-analysis have been based on search in the MEDLINE, EMBASE, and Cochrane Library for studies published up to August 2022. The primary outcomes were overall pooled rates of major bleeding (MB) and minor bleeding (mB), worsening renal function (WRF), bradycardia/conduction disturbance (BCD), and PE-related and all- cause mortality in patients who underwent ART. Results: Among the 233 studies documented at initial search, 24 studies were eligible for meta-analysis, and a total of 427 PE patients who underwent ART were evaluated. Overall pooled rates of MB and mB were 9.6% (95% CI 5.9%-15.2%) and 9.2% (95% CI 6.1%13.6%), transient BCD and WRF were 18.2% (95% CI 12.4%-26%) and 15% (95% CI 10%21.8%), and PE-related death and all-cause death were 12.7% (95% CI 9.1%-17.3%) and 15% (95% CI 11%-20%), respectively. However, significant heterogeneity and some evidence of funnel plot asymmetry and publication bias were noted for MB, BCD and WRF, but not for PE-related death and all-cause death. Conclusion: Overall pooled rates of bleeding events, BCD and WRF episodes, PE-related death and all-cause death may be considered as encouraging results for efficacy and safety issues of ART utilization in specific scenarios of acute PE, and a reappraisal for black-box warning on ART seems to be necessary.
- Open Access
- 1 July 2023
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 27 (7) , 423-+
A Novel Composed Index to Evaluate the Right Ventricle Free-Wall Adaptation Against Ventricular Wall Stress in Acute Pulmonary Embolism
Background: Pulmonary embolism severity index and simplified pulmonary embolism severity index have been utilized in initial risk evaluation in patients with acute pulmonary embolism. However, these models do not include any imaging measure of right ventricle function. In this study, we proposed a novel index and aimed to evaluate the clinical impact.Methods: Our study population comprised retrospectively evaluated 502 patients with acute pulmonary embolism managed with different treatment modalities. Echocardiographic and computed tomographic pulmonary angiography evaluations were performed at admission to the emergency room within maximally 30 minutes. The formula of our index was as follows: (right ventricle diameter x systolic pulmonary arterial pressure-echo)/(right ventricle free-wall diameter x tricuspid annular plane systolic excursion).Results: This index value showed significant correlations to clinical and hemodynamic severity measures. Only pulmonary embolism severity index, but not our index value, independently predicted in-hospital mortality. However, an index value higher than 17.8 predicted the long-term mortality with a sensitivity of 70% and specificity of 40% (areas under the curve = 0.652, 95% CI, 0.557-0.747, P = .001). According to the adjusted variable plot, the risk of long-term mortality increased until an index level of 30 but remained unchanged thereafter. The cumulative hazard curve also showed a higher mortality with high-index value versus low-index value.Conclusions: Our index composed from measures of computed tomographic pulmonary angiography and transthoracic echocardiography may provide important insights regarding the adaptation status of right ventricle against pressure/wall stress in acute pulmonary embolism, and a higher value seems to be associated with severity of the clinical and hemodynamic status and long-term mortality but not with in-hospital mortality. However, the pulmonary embolism severity index remained as the only independent predictor for in-hospital mortality.
- 1 July 2023
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 27 (7) , 423-+
Open AccessA Novel Composed Index to Evaluate the Right Ventricle Free-Wall Adaptation Against Ventricular Wall Stress in Acute Pulmonary Embolism
Background: Pulmonary embolism severity index and simplified pulmonary embolism severity index have been utilized in initial risk evaluation in patients with acute pulmonary embolism. However, these models do not include any imaging measure of right ventricle function. In this study, we proposed a novel index and aimed to evaluate the clinical impact.Methods: Our study population comprised retrospectively evaluated 502 patients with acute pulmonary embolism managed with different treatment modalities. Echocardiographic and computed tomographic pulmonary angiography evaluations were performed at admission to the emergency room within maximally 30 minutes. The formula of our index was as follows: (right ventricle diameter x systolic pulmonary arterial pressure-echo)/(right ventricle free-wall diameter x tricuspid annular plane systolic excursion).Results: This index value showed significant correlations to clinical and hemodynamic severity measures. Only pulmonary embolism severity index, but not our index value, independently predicted in-hospital mortality. However, an index value higher than 17.8 predicted the long-term mortality with a sensitivity of 70% and specificity of 40% (areas under the curve = 0.652, 95% CI, 0.557-0.747, P = .001). According to the adjusted variable plot, the risk of long-term mortality increased until an index level of 30 but remained unchanged thereafter. The cumulative hazard curve also showed a higher mortality with high-index value versus low-index value.Conclusions: Our index composed from measures of computed tomographic pulmonary angiography and transthoracic echocardiography may provide important insights regarding the adaptation status of right ventricle against pressure/wall stress in acute pulmonary embolism, and a higher value seems to be associated with severity of the clinical and hemodynamic status and long-term mortality but not with in-hospital mortality. However, the pulmonary embolism severity index remained as the only independent predictor for in-hospital mortality.
- Open Access
- 28 November 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (12) , 902-913
Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Arterial Hypertension: A Single-Center Experience and Review of Current Literature
Pulmonary arterial hypertension,mortality,pregnancy
- 28 November 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (12) , 902-913
Open AccessMaternal and Fetal Outcomes in Pregnant Women with Pulmonary Arterial Hypertension: A Single-Center Experience and Review of Current Literature
Pulmonary arterial hypertension,mortality,pregnancy
- Open Access
- 1 October 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (10) , 778-787
The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience
Macitentan,pulmonary arterial hypertension,Eisenmenger syndrome,REVEAL-Lite 2,COMPERA,SPAHR
- 1 October 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (10) , 778-787
Open AccessThe Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience
Macitentan,pulmonary arterial hypertension,Eisenmenger syndrome,REVEAL-Lite 2,COMPERA,SPAHR
- Open Access
- 1 September 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (9) , 717-724
Eosinophil-to-Monocyte Ratio as a Candidate for a Novel Prognostic Marker in Acute Pulmonary Embolism: Is it a Consumptive Mechanism?
Acute pulmonary embolism,ultrasound-assisted thrombolysis,eosinophil to monocyte ratio,rheolytic thrombectomy,prognostic biomarkers
- 1 September 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (9) , 717-724
Open AccessEosinophil-to-Monocyte Ratio as a Candidate for a Novel Prognostic Marker in Acute Pulmonary Embolism: Is it a Consumptive Mechanism?
Acute pulmonary embolism,ultrasound-assisted thrombolysis,eosinophil to monocyte ratio,rheolytic thrombectomy,prognostic biomarkers
- Open Access
- 31 May 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (6) , 499-500
Reply to Letter to the Editor: “How Little Things Can Make a Big Difference?”
- 31 May 2022
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (6) , 499-500
Open AccessReply to Letter to the Editor: “How Little Things Can Make a Big Difference?”
- Open Access
- 1 April 2022
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 25 (1) , 95-101
Evaluation of Nosocomial Infections and Related Hospital Mortality in Coronary Intensive Care Unit
Introduction: Mechanical/therapeutic technologies have resulted in an increased risk of infections including ventilator-associated pneumonia, central line-associated bloodstream infections, and potentially increased the risk of care process complications such as anesthesia/intubation/sedation complications; central line infections, stress ulcers, delirium, and the use of inappropriate or false medications in coronary intensive care units. These complications are associated with significantly increased in-hospital mortality, morbidity, length of stay, and/or healthcare costs and are potentially preventable. We aimed to evaluate the nosocomial infections developed in the coronary intensive care unit and the relationship between coronary intensive care unit infections and in-hospital mortality. Patients and Methods: The data of 500 patients followed in the coronary intensive care unit more than 48 hours between 01.01.2019 and 31.12.2020 were retrospectively analyzed. Patient records were obtained from surveillance data obtained by infectious diseases and clinical microbiology specialists and infection control nurses through daily visits. The criteria determined by the Centers for Disease Control and Prevention were used in the diagnosis of nosocomial infections. Various clinical samples (blood, urine, endotracheal aspiration fluid) taken from the patients were processed in the microbiology laboratory using qualitative or quantitative methods. Results: The most common detected infection type was catheter-related bloodstream infection (79.1%), followed by catheter-associated urinary tract infection (18.7%) and ventilator-associated pneumonia (6.25%) respectively. Gram-negative bacillus infections accounted for 70.8% of the causative agents, gram-positive cocci for 20.18%, and fungal infections for 12.5%. The most frequently detected microorganism species were Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) [7 (14.5%), 6 (12.5%)] respectively. Central venous catheter use was more common in non-infected group than infected group [45.0 (93.8%), 50.0 (73.5%) p= 0.005]. Continuous renal replacement therapy was more common in infected group compared to non-infected group [32 (66.7%), 21 (30.9%) p< 0.001]. The numbers of intubated days were higher in the infected group than in the non-infected group and this was statistically significant [mean (SD) 9.9 ± 9.2, 2.3 ± 2.9, P< 0.001]. In-hospital mortality rates were higher in infected group compared to non-infected group [28 (58.3%), 19 (27.9%), p= 0.001]. Conclusion: We found a significant relationship between nosocomial infections and in-hospital mortality in patients who were followed in coronary intensive care unit more than 48 hours [OR= 3.52 (1.30-9.53 CI= 95%) P= 0.01]. The most common sites of nosocomial infections are catheter-related bloodstream infections followed by catheter-associated urinary tract infections and ventilator-associated pneumonia. In multidisciplinary coronary intensive care units, daily visits with infectious diseases and clinical microbiology specialists and infection control nurses, close clinical and laboratory follow-up (detection of fever, elevation in procalcitonin and C-reactive protein (CRP) levels) are indispensable and more importantly nosocomial infections and infection-related mortality are preventable.
- 1 April 2022
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 25 (1) , 95-101
Open AccessEvaluation of Nosocomial Infections and Related Hospital Mortality in Coronary Intensive Care Unit
Introduction: Mechanical/therapeutic technologies have resulted in an increased risk of infections including ventilator-associated pneumonia, central line-associated bloodstream infections, and potentially increased the risk of care process complications such as anesthesia/intubation/sedation complications; central line infections, stress ulcers, delirium, and the use of inappropriate or false medications in coronary intensive care units. These complications are associated with significantly increased in-hospital mortality, morbidity, length of stay, and/or healthcare costs and are potentially preventable. We aimed to evaluate the nosocomial infections developed in the coronary intensive care unit and the relationship between coronary intensive care unit infections and in-hospital mortality. Patients and Methods: The data of 500 patients followed in the coronary intensive care unit more than 48 hours between 01.01.2019 and 31.12.2020 were retrospectively analyzed. Patient records were obtained from surveillance data obtained by infectious diseases and clinical microbiology specialists and infection control nurses through daily visits. The criteria determined by the Centers for Disease Control and Prevention were used in the diagnosis of nosocomial infections. Various clinical samples (blood, urine, endotracheal aspiration fluid) taken from the patients were processed in the microbiology laboratory using qualitative or quantitative methods. Results: The most common detected infection type was catheter-related bloodstream infection (79.1%), followed by catheter-associated urinary tract infection (18.7%) and ventilator-associated pneumonia (6.25%) respectively. Gram-negative bacillus infections accounted for 70.8% of the causative agents, gram-positive cocci for 20.18%, and fungal infections for 12.5%. The most frequently detected microorganism species were Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) [7 (14.5%), 6 (12.5%)] respectively. Central venous catheter use was more common in non-infected group than infected group [45.0 (93.8%), 50.0 (73.5%) p= 0.005]. Continuous renal replacement therapy was more common in infected group compared to non-infected group [32 (66.7%), 21 (30.9%) p< 0.001]. The numbers of intubated days were higher in the infected group than in the non-infected group and this was statistically significant [mean (SD) 9.9 ± 9.2, 2.3 ± 2.9, P< 0.001]. In-hospital mortality rates were higher in infected group compared to non-infected group [28 (58.3%), 19 (27.9%), p= 0.001]. Conclusion: We found a significant relationship between nosocomial infections and in-hospital mortality in patients who were followed in coronary intensive care unit more than 48 hours [OR= 3.52 (1.30-9.53 CI= 95%) P= 0.01]. The most common sites of nosocomial infections are catheter-related bloodstream infections followed by catheter-associated urinary tract infections and ventilator-associated pneumonia. In multidisciplinary coronary intensive care units, daily visits with infectious diseases and clinical microbiology specialists and infection control nurses, close clinical and laboratory follow-up (detection of fever, elevation in procalcitonin and C-reactive protein (CRP) levels) are indispensable and more importantly nosocomial infections and infection-related mortality are preventable.
- 20 December 2021
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 77 (3) , 204-210
Ischaemic versus non-ischaemic: how does heart failure aetiology affect pulmonary arterial capacitance and pulmonary artery pulsatility index in end-stage heart failure?
The aetiology of heart failure may have different effects on right ventricular (RV) function, pulmonary pressures and RV afterload. Pulmonary arterial capacitance (PAC) and pulmonary artery pulsati...
- 20 December 2021
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 77 (3) , 204-210
Ischaemic versus non-ischaemic: how does heart failure aetiology affect pulmonary arterial capacitance and pulmonary artery pulsatility index in end-stage heart failure?
The aetiology of heart failure may have different effects on right ventricular (RV) function, pulmonary pressures and RV afterload. Pulmonary arterial capacitance (PAC) and pulmonary artery pulsati...
- Open Access
- 29 November 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (12) , 902-911
A seven-year single-center experience on AngioJet rheolytic thrombectomy in patients with pulmonary embolism at high risk and intermediate-high risk
AngioJet rheolytic thrombectomy (ART) has been used as a catheter-based treatment for acute pulmonary embolism (PE). In this study, based on our 7-year experience with ART in patients with PE, we evaluated the efficacy and safety outcomes of ART. Our study is based on retrospective evaluation of 56 patients with high- and intermediate-high-risk PE, with an average age of 62 years [interquartile range (IQR) 50–73 years] who underwent ART. High and intermediate-high risks were noted in 21.4% and 78.6% of the patients, respectively. The ART duration was 304 (IQR: 246–468) seconds. Measures of obstruction, right to left ventricle diameter ratio, right to left atrial diameter ratio, and pulmonary arterial pressures were improved (p<0.001 for all). During the hospital stay, acute renal failure, major and minor bleeding, and mortality rates were 37.5%, 7.1%, 12.5%, and 8.9%, respectively. Aging related to post-procedural nephropathy while high-risk status was associated with in-hospital mortality (p=0.006) and long-term mortality. ART resulted in significant and clinically relevant improvements in the pulmonary arterial thrombotic burden, right ventricle strain, and hemodynamics in patients with PE at high and intermediate-high risk. Aging increased the risk of post-procedural nephropathy, whereas baseline high-risk status predicted in-hospital and long-term mortality.
- 29 November 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (12) , 902-911
Open AccessA seven-year single-center experience on AngioJet rheolytic thrombectomy in patients with pulmonary embolism at high risk and intermediate-high risk
AngioJet rheolytic thrombectomy (ART) has been used as a catheter-based treatment for acute pulmonary embolism (PE). In this study, based on our 7-year experience with ART in patients with PE, we evaluated the efficacy and safety outcomes of ART. Our study is based on retrospective evaluation of 56 patients with high- and intermediate-high-risk PE, with an average age of 62 years [interquartile range (IQR) 50–73 years] who underwent ART. High and intermediate-high risks were noted in 21.4% and 78.6% of the patients, respectively. The ART duration was 304 (IQR: 246–468) seconds. Measures of obstruction, right to left ventricle diameter ratio, right to left atrial diameter ratio, and pulmonary arterial pressures were improved (p<0.001 for all). During the hospital stay, acute renal failure, major and minor bleeding, and mortality rates were 37.5%, 7.1%, 12.5%, and 8.9%, respectively. Aging related to post-procedural nephropathy while high-risk status was associated with in-hospital mortality (p=0.006) and long-term mortality. ART resulted in significant and clinically relevant improvements in the pulmonary arterial thrombotic burden, right ventricle strain, and hemodynamics in patients with PE at high and intermediate-high risk. Aging increased the risk of post-procedural nephropathy, whereas baseline high-risk status predicted in-hospital and long-term mortality.
- Open Access
- 1 October 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (10) , 733-740
Impaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?
Objective: Endothelium-dependent (ED) and endothelium-independent (EI) flow-mediated vasodilatation (FMD) have been used as measures of systemic arterial vasodilatory reserve. In this study, we aimed to assess both ED-FMD and EI-FMD in different groups with pulmonary hypertension (PH), and to investigate the relationship of these measures with clinical, echocardiographic, and invasive parameters of diseases severity and targeted treatment status. Methods: Our study population comprised 41 patients with PH [28 (68.2%) women, age 46.3 +/- 19.6 years] including idiopathic pulmonary arterial hypertension, Eisenmenger syndrome, and chronic thromboembolic PH in whom diagnosis were confirmed in accordance with current guidelines and 17 age and sex-matched healthy controls. The brachial artery (BA) was used for assessment of FMD with Duplex ultrasound, and serial changes in diameter were recorded at baseline, 1, and 3 minutes after termination of 2-minute external occlusive compression for ED-FMD, and after sublingual intake of glycerol trinitrate for EI-FMD, respectively. Results: Compared with controls, overall the PH group showed significantly lower ED-FMD (0.65 +/- 0.21 vs. 0.30 +/- 0.23 and 0.65 +/- 0.18 vs. 0.24 +/- 0.21) and EI-FMD (0.67 +/- 0.15 vs. 0.37 +/- 0.25 and 0.75 +/- 0.20 vs. 0.32 +/- 0.24) responses at 1st and 3rd min (p0.05). Conclusion: Our results suggest an impaired BA vasodilatory reserve in patients with PH regardless of the clinical subgroup. Although these findings seem to be consistent with systemic dysfunction, acute FMD may not reflect the severity of PH and cannot be used as a potential surrogate for outcome in this setting.
- 1 October 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (10) , 733-740
Open AccessImpaired endothelium-dependent and endothelium-independent systemic vasodilatory reserve in pulmonary hypertension regardless the clinical group: A generalized dysfunction beyond the pulmonary arteries?
Objective: Endothelium-dependent (ED) and endothelium-independent (EI) flow-mediated vasodilatation (FMD) have been used as measures of systemic arterial vasodilatory reserve. In this study, we aimed to assess both ED-FMD and EI-FMD in different groups with pulmonary hypertension (PH), and to investigate the relationship of these measures with clinical, echocardiographic, and invasive parameters of diseases severity and targeted treatment status. Methods: Our study population comprised 41 patients with PH [28 (68.2%) women, age 46.3 +/- 19.6 years] including idiopathic pulmonary arterial hypertension, Eisenmenger syndrome, and chronic thromboembolic PH in whom diagnosis were confirmed in accordance with current guidelines and 17 age and sex-matched healthy controls. The brachial artery (BA) was used for assessment of FMD with Duplex ultrasound, and serial changes in diameter were recorded at baseline, 1, and 3 minutes after termination of 2-minute external occlusive compression for ED-FMD, and after sublingual intake of glycerol trinitrate for EI-FMD, respectively. Results: Compared with controls, overall the PH group showed significantly lower ED-FMD (0.65 +/- 0.21 vs. 0.30 +/- 0.23 and 0.65 +/- 0.18 vs. 0.24 +/- 0.21) and EI-FMD (0.67 +/- 0.15 vs. 0.37 +/- 0.25 and 0.75 +/- 0.20 vs. 0.32 +/- 0.24) responses at 1st and 3rd min (p0.05). Conclusion: Our results suggest an impaired BA vasodilatory reserve in patients with PH regardless of the clinical subgroup. Although these findings seem to be consistent with systemic dysfunction, acute FMD may not reflect the severity of PH and cannot be used as a potential surrogate for outcome in this setting.